Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?

Jalpa Devi, Aimun Raees, Amna Subhan Butt

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Abstract

Recently, a single letter change has taken the world by storm. A group of experts have developed a consensus to upgrade the term non-alcoholic fatty liver disease (NAFLD) to metabolic associated fatty liver disease (MAFLD), suggesting that MAFLD would more accurately reflect not only the disease pathogenesis but would also help in patient stratification for management with NAFLD. However, the difference of opinion exists, which has made the NAFLD vs MAFLD debate the current talk of the town.

Original languageEnglish (US)
Pages (from-to)158-167
Number of pages10
JournalWorld Journal of Hepatology
Volume14
Issue number1
DOIs
Publication statusPublished - 2022

Keywords

  • Fatty liver disease
  • Metabolic associated fatty liver disease
  • Non-alcoholic fatty liver
  • Non-alcoholic fatty liver disease
  • Review

Fingerprint

Dive into the research topics of 'Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?'. Together they form a unique fingerprint.

Cite this